Spots Global Cancer Trial Database for head and neck tumors
Every month we try and update this database with for head and neck tumors cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Fosbretabulin or Placebo in Combination With Carboplatin/Paclitaxel in Anaplastic Thyroid Cancer | NCT01701349 | Anaplastic Thyr... | Fosbretabulin +... Placebo + pacli... | 18 Years - | Mateon Therapeutics | |
| Phase I Chemoprevention Trial With Green Tea Polyphenon E & Erlotinib in Patients With Premalignant Lesions of the Head & Neck | NCT01116336 | Cancer of Head ... Neoplasms, Head... | Erlotinib Green Tea Polyp... | 18 Years - | Emory University | |
| Tislelizumab Combined APF Chemotherapy in the Treatment of Locally Advanced Head and Neck Tumors | NCT05758389 | Head and Neck T... | Tislelizumab, P... | 18 Years - 75 Years | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School | |
| Randomized, Open-label Economic and Medical Study on the Lymph Node Management of Squamous Cell Carcinoma of the Oral Cavity and Oropharynx Tumor Stage 1 or 2, Nodes 0 (T1-T2 N0) Operable | NCT02855723 | Head and Neck T... | Surgery: GS str... Surgery: Classi... | 18 Years - | University Hospital, Montpellier | |
| Analysis of HPV and Biomarkers Present in the Biological Fluids of Patients Suffering From Head and Neck Cancer as a Non-invasive Strategy for Detecting Recurrence | NCT06224166 | Head and Neck T... | Collection and ... | 18 Years - | Regina Elena Cancer Institute | |
| Fosbretabulin or Placebo in Combination With Carboplatin/Paclitaxel in Anaplastic Thyroid Cancer | NCT01701349 | Anaplastic Thyr... | Fosbretabulin +... Placebo + pacli... | 18 Years - | Mateon Therapeutics | |
| Phase I Trial From GRID 18F-FDG-PET Biological Imaging-guided Intensitymodulated Radiotherapy (BG-IMRT) With Patients With Recurrent or New Head or Neck Tumor in Previously Radiated Area | NCT00528294 | Head and Neck T... | GRID radiothera... | 18 Years - | University Hospital, Ghent | |
| Study of Copper Isotope in Head and Neck Cancer | NCT02864836 | Head and Neck T... | Samples collect... | 18 Years - | Lille Catholic University | |
| Stereotactic Body Radiotherapy for Head and Neck Tumors | NCT01344356 | Squamous Cell C... Nasopharyngeal ... Salivary Gland ... Head and Neck S... Paraganglioma o... Chordoma of Hea... Chondrosarcoma ... Angiofibroma of... | stereotactic bo... Stereotactic bo... | 18 Years - | Mercy Research | |
| Randomized, Open-label Economic and Medical Study on the Lymph Node Management of Squamous Cell Carcinoma of the Oral Cavity and Oropharynx Tumor Stage 1 or 2, Nodes 0 (T1-T2 N0) Operable | NCT02855723 | Head and Neck T... | Surgery: GS str... Surgery: Classi... | 18 Years - | University Hospital, Montpellier | |
| Effectiveness of autoHYpnosis in the Prevention of Anxiety During Radiotherapy of Head and Neck Tumors (HYMACO) | NCT04671485 | Head and Neck T... | Standard care Autohypnosis Musicotherapy | 18 Years - | Institut de Cancérologie de Lorraine | |
| Phase I Chemoprevention Trial With Green Tea Polyphenon E & Erlotinib in Patients With Premalignant Lesions of the Head & Neck | NCT01116336 | Cancer of Head ... Neoplasms, Head... | Erlotinib Green Tea Polyp... | 18 Years - | Emory University | |
| Study of Copper Isotope in Head and Neck Cancer | NCT02864836 | Head and Neck T... | Samples collect... | 18 Years - | Lille Catholic University | |
| Randomized, Open-label Economic and Medical Study on the Lymph Node Management of Squamous Cell Carcinoma of the Oral Cavity and Oropharynx Tumor Stage 1 or 2, Nodes 0 (T1-T2 N0) Operable | NCT02855723 | Head and Neck T... | Surgery: GS str... Surgery: Classi... | 18 Years - | University Hospital, Montpellier | |
| Tislelizumab Combined APF Chemotherapy in the Treatment of Locally Advanced Head and Neck Tumors | NCT05758389 | Head and Neck T... | Tislelizumab, P... | 18 Years - 75 Years | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
